(Date:12/3/2009)... SHP, Nasdaq: SHPGY ), the global specialty biopharmaceutical ... and voluntary market withdrawal of one lot of the ... taking this action because some Daytrana patches do not ... release liner removal specification, and as a result, patients ...
(Date:12/2/2009)... COLUMBIA, Md., Dec. 2 Martek Biosciences Corporation (Nasdaq: ... results of its fourth quarter and fiscal year 2009 on ... Following the release, at 4:45 p.m. ET Martek will ... All interested parties may listen to the call live ...
(Date:12/2/2009)... NEW YORK, Dec. 2 Nearly 600 medical research ... explore novel development approaches and innovative funding strategies at ... ,, FasterCures, the Washington-based center of the ... facilitate multi-sector collaborations needed to turn a scientific discovery ...
(Date:12/2/2009)... Pepscan Holding NV,the Netherlands based biotechnology company focusing on ... announced that it,has appointed Wim E.M. Mol, Ph.D. as ... Dr. Mol will be responsible for all of Pepscans ... the company. He brings to,Pepscan more than 20 years ...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Dutch Biotech Company Pepscan Appoints New CEO 2... ... First Non-GAAP Profit; Sales Guidance Revised Upward, ... and Cancer, First Quarter 2008 Financial Highlights:, - Soliris(R) (eculizumab) net product sales were $45.5 ... 2007., - Q1 GAAP net loss was $4.2 million, or $0.11 net loss per share, compared ...
... Inc. (Nasdaq: SEPR ), FRAMINGHAM, Mass. ... HTW) today announced that,veteran healthcare executive Timothy J. ... non- executive director, effective immediately., Barberich, 60, ... and chairman of Marlborough, MA-based Sepracor Inc., a ...
... 29 RediClinic LLC announced today,that it is ... Inc.,to provide free diabetes screenings to school age ... identify diabetic and pre-diabetic children and,adolescents. Beginning May ... the,diabetes screenings will be available free of charge ...
Other Biology Technology:Alexion Reports First Quarter 2008 Results 2Alexion Reports First Quarter 2008 Results 3Alexion Reports First Quarter 2008 Results 4Alexion Reports First Quarter 2008 Results 5Alexion Reports First Quarter 2008 Results 6Alexion Reports First Quarter 2008 Results 7Alexion Reports First Quarter 2008 Results 8Alexion Reports First Quarter 2008 Results 9Alexion Reports First Quarter 2008 Results 10Alexion Reports First Quarter 2008 Results 11Alexion Reports First Quarter 2008 Results 12HeartWare Appoints Timothy J. Barberich to Board of Directors 2RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 2RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 3RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 4RediClinic, BIOSAFE Labs and Glycemion to Provide Free Diabetes Risk Assessments to Richmond, Va. School Children 5... National Institutes of Health (NIH) has selected the ... the Genes, Environment and Health Initiative (GEI), a ... , "This is ground-breaking research in understanding the ... said Department of Health and Human Services Secretary ...
... Reader to be the Latest Addition to M2SYS, ... ... Technology, a biometric,technology research and development firm, announced today its ... Plus. The Hamster Plus fingerprint reader features innovative Auto-On,technology ...
... N.Y., Aug. 15 bioMETRX, Inc. (OTC,Bulletin Board: BMRX), ... announced that it is has provided notice to,certain holders ... holders,must surrender said warrants to the company by August ... series B $0.10 warrants that it,has elected to pay ...
Other Biology News:Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 2Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 3Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 4Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 5Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 6Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 7Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 8Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring 9M2SYS Partners with SecuGen Corporation to Support Market Leading Hamster Plus Fingerprint Reader with Auto-On Technology 2bioMETRX, Inc. Calls Series B Warrants 2Mouse monoclonal [CP23] to Ricin communis ( Abpromise for all tested applications)....
Rabbit polyclonal to Testosterone 19 ( Abpromise for all tested applications). Antigen: Testosterone 19 CME HSA (Human)...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Biology Products: